AVEO Oncology
AVEO
#7248
Rank
NZ$0.88 B
Marketcap
NZ$25.41
Share price
0.00%
Change (1 day)
172.77%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$90.35 Million a decrease over its 2020 earnings that were of -NZ$60.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-50.79%
2021 -NZ$90.35 Million49.9%
2020 -NZ$60.27 Million-479.04%
2019 NZ$15.9 M-276.17%
2018 -NZ$9.03 Million-91.79%
2017 -NZ$0.11 Billion142.38%
2016 -NZ$45.37 Million78.51%
2015 -NZ$25.42 Million-71.55%
2014 -NZ$89.33 Million-50.72%
2013 -NZ$0.19 Billion-4.88%
2012 -NZ$0.2 Billion-426.29%
2011 NZ$58.4 M-159.85%
2010 -NZ$97.6 Million35.33%
2009 -NZ$72.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$52.71 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.39 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.74 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.73 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.25 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.83 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA